牛牛AI助理已提取核心訊息
On January 9, 2024, Cardinal Health, Inc. released a news update announcing significant progress in its ongoing business and portfolio review. The company has updated its fiscal year 2024 non-GAAP diluted earnings per share (EPS) outlook, now expecting to reach the higher end of the $6.75 to $7.00 range. This positive adjustment is primarily attributed to favorable conditions in Interest and Other and Diluted Weighted Average Shares Outstanding, bolstered by strong cash flow and an additional $250 million share repurchase in Q2 of fiscal 2024. Cardinal Health also provided an update on its Medical segment profit for the quarter ending December 31, 2023, and detailed its new enterprise operating and segment reporting structure, which will be reflected in financial reports starting in the third quarter of fiscal 2024. The company...Show More
On January 9, 2024, Cardinal Health, Inc. released a news update announcing significant progress in its ongoing business and portfolio review. The company has updated its fiscal year 2024 non-GAAP diluted earnings per share (EPS) outlook, now expecting to reach the higher end of the $6.75 to $7.00 range. This positive adjustment is primarily attributed to favorable conditions in Interest and Other and Diluted Weighted Average Shares Outstanding, bolstered by strong cash flow and an additional $250 million share repurchase in Q2 of fiscal 2024. Cardinal Health also provided an update on its Medical segment profit for the quarter ending December 31, 2023, and detailed its new enterprise operating and segment reporting structure, which will be reflected in financial reports starting in the third quarter of fiscal 2024. The company's Medical Segment has completed a review of its growth businesses, deciding to invest in at-Home Solutions and OptiFreight Logistics for long-term growth. Additionally, the company is continuing its review of the Global Medical Products and Distribution business, focusing on operational performance. Cardinal Health will host a conference call to discuss these announcements and will present at the 42nd Annual J.P. Morgan Healthcare Conference. The company's updated segment reporting structure includes two reportable segments: Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD), with Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight Logistics reported as Other. The company reiterated its long-term financial targets, reflecting 12% to 14% growth in non-GAAP diluted EPS, and provided pro-forma long-term targets for the updated segment reporting structure.
2024年1月9日，Cardinal Health, Inc.發佈了最新消息，宣佈其正在進行的業務和投資組合審查取得了重大進展。該公司更新了其2024財年非公認會計准則攤薄後每股收益（EPS）展望，目前預計將達到6.75美元至7.00美元區間的較高水平。這一積極調整主要歸因於利息和其他及攤薄後的加權平均已發行股票的有利條件，這得益於強勁的現金流以及2024財年第二季度額外的2.5億美元股票回購。Cardinal Health還提供了截至2023年12月31日的季度醫療板塊利潤的最新情況，並詳細介紹了其新的企業運營和分部報告結構，該結構將反映在2024財年第三季度開始的財務報告中。該公司的醫療部...展開全部
2024年1月9日，Cardinal Health, Inc.發佈了最新消息，宣佈其正在進行的業務和投資組合審查取得了重大進展。該公司更新了其2024財年非公認會計准則攤薄後每股收益（EPS）展望，目前預計將達到6.75美元至7.00美元區間的較高水平。這一積極調整主要歸因於利息和其他及攤薄後的加權平均已發行股票的有利條件，這得益於強勁的現金流以及2024財年第二季度額外的2.5億美元股票回購。Cardinal Health還提供了截至2023年12月31日的季度醫療板塊利潤的最新情況，並詳細介紹了其新的企業運營和分部報告結構，該結構將反映在2024財年第三季度開始的財務報告中。該公司的醫療部門已完成對其成長型業務的審查，決定投資家居解決方案和OptiFreight Logistics以實現長期增長。此外，該公司正在繼續審查全球醫療產品和分銷業務，重點是運營業績。Cardinal Health將主持電話會議討論這些公告，並將出席第42屆摩根大通醫療保健年度會議。該公司更新的分部報告結構包括兩個可報告的板塊：製藥和特種解決方案以及全球醫療產品與分銷（GMPD），核和精準健康解決方案、家居解決方案和OptiFreight Logistics列爲其他。該公司重申了其長期財務目標，反映了非公認會計准則攤薄後每股收益的12％至14％的增長，併爲更新的分部報告結構提供了預期的長期目標。
有用
沒用
